ABVC BioPharma, Inc. Debt and Equity Securities, Gain (Loss)
ABVC BioPharma, Inc. (ABVC) reported Debt and Equity Securities, Gain (Loss) of -$44.92 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:DebtAndEquitySecuritiesGainLoss · last filed 2025-08-13
- ABVC BioPharma, Inc. debt and equity securities, gain (loss) for the quarter ending 2025-06-30 was -$44.92K.
- ABVC BioPharma, Inc. debt and equity securities, gain (loss) for the quarter ending 2024-06-30 was -$79.06K.
| Period end | Debt and Equity Securities, Gain (Loss) 3 month | Debt and Equity Securities, Gain (Loss) 6 month |
|---|---|---|
| 2025-06-30 | -$44.92K 10-Q · filed 2025-08-13 | -$95.79K 10-Q · filed 2025-08-13 |
| 2024-06-30 | -$79.06K 10-Q · filed 2025-08-13 | -$79.06K 10-Q · filed 2025-08-13 |